Search｜Photos & Images & Videos｜KYODO NEWS IMAGES INC

Malaysians mark Eid al-Fitr as COVID-19 cases subside

STORY: Malaysians mark Eid al-Fitr as COVID-19 cases subside DATELINE: May 4, 2022 LENGTH: 00:05:18 LOCATION: Kuala Lumpur CATEGORY: SOCIETY/HEALTH SHOTLIST: 1. Various of Malaysia's national flag in front of prime minister's office 2. Various of crowds in Putrajaya 3. Various of Muslims praying in mosque 4. Various of crowds at mosque after the prayer 5. Various of crowds posing for photos STORYLINE: Malaysia's Muslims marked a more joyous Eid al-Fitr festival on Monday as the COVID-19 situation in the country continues to improve. After having endured lockdowns and travel restrictions, Malaysians were teeming in the capital Kuala Lumpur in streets, malls and markets, celebrating the end of Ramadan and the start of Eid al-Fitr holidays, while others are finally able to make the traditional exodus of "Balik Kampung," or people returning to hometowns. Health Minister Khairy Jamaluddin said last week that the practice of hosting open houses and home visits will be allowed again this year, along with other

E

Robert Markovic, Martin Balik

The General Teaching Hospital (VFN) in Prague released to home care Robert Markovic (left), the man who has been the first patient with COVID 19 treated by the remdesivir experimental drug in Czechia, today, on Tueday, May 5, 2020. The 53-year-old taxi driver was hospitalised with a severe course of the COVID-19 disease on March 10. He received remdesivir intravenously for ten days at the end of March and the beginning of April. On the right side is seen doctor Martin Balik. (CTK Photo/Michal Krumphanzl)

E

Martin Balik, David Feltl

The General Teaching Hospital in Prague (VFN) completed the treatment of a COVID-19 patient, 53, with the Remdesivir experimental drug, the only patient treated with the drug in the Czech Republic so far, the VFN Anaesthesiology Clinic deputy head Martin Balik, left, and VFN director David Feltl reported today, on Friday, April 3, 2020, in Prague, Czech Republic. (CTK Photo/Katerina Sulova)

E

Martin Balik, David Feltl

The General Teaching Hospital in Prague (VFN) completed the treatment of a COVID-19 patient, 53, with the Remdesivir experimental drug, the only patient treated with the drug in the Czech Republic so far, the VFN Anaesthesiology Clinic deputy head Martin Balik, left, and VFN director David Feltl reported today, on Friday, April 3, 2020, in Prague, Czech Republic. (CTK Photo/Katerina Sulova)

E

Martin Balik, David Feltl

The General Teaching Hospital in Prague (VFN) completed the treatment of a COVID-19 patient, 53, with the Remdesivir experimental drug, the only patient treated with the drug in the Czech Republic so far, the VFN Anaesthesiology Clinic deputy head Martin Balik, left, and VFN director David Feltl reported today, on Friday, April 3, 2020, in Prague, Czech Republic. (CTK Photo/Katerina Sulova)

E

Martin Balik, David Feltl

The General Teaching Hospital in Prague (VFN) completed the treatment of a COVID-19 patient, 53, with the Remdesivir experimental drug, the only patient treated with the drug in the Czech Republic so far, the VFN Anaesthesiology Clinic deputy head Martin Balik, left, and VFN director David Feltl reported today, on Friday, April 3, 2020, in Prague, Czech Republic. (CTK Photo/Katerina Sulova)

E

Martin Balik

Doctor Martin Balik of the General Teaching Hospital in Prague speaks during a press conference on coronavirus treatment, on March 27, 2020, in Prague, Czech Republic. The condition of a Czech COVID-19 patient has markedly improved after the U.S. remdesivir experimental medicine was administered to him for three days. (CTK Photo/Michal Krumphanzl)

E

Martin Balik, David Feltl

Doctor Martin Balik, left, and director of the General Teaching Hospital in Prague David Feltl, right, speak during a press conference on coronavirus treatment, on March 27, 2020, in Prague, Czech Republic. The condition of a Czech COVID-19 patient has markedly improved after the U.S. remdesivir experimental medicine was administered to him for three days. (CTK Photo/Michal Krumphanzl)

E

Martin Balik, David Feltl

Doctor Martin Balik, left, and director of the General Teaching Hospital in Prague David Feltl, right, speak during a press conference on coronavirus treatment, on March 27, 2020, in Prague, Czech Republic. The condition of a Czech COVID-19 patient has markedly improved after the U.S. remdesivir experimental medicine was administered to him for three days. (CTK Photo/Michal Krumphanzl)

E

Martin Balik, David Feltl

Doctor Martin Balik, left, and director of the General Teaching Hospital in Prague David Feltl, right, speak during a press conference on coronavirus treatment, on March 27, 2020, in Prague, Czech Republic. The condition of a Czech COVID-19 patient has markedly improved after the U.S. remdesivir experimental medicine was administered to him for three days. (CTK Photo/Michal Krumphanzl)

E

Martin Balik, David Feltl

Doctor Martin Balik, left, and director of the General Teaching Hospital in Prague David Feltl, right, speak during a press conference on coronavirus treatment, on March 27, 2020, in Prague, Czech Republic. The condition of a Czech COVID-19 patient has markedly improved after the U.S. remdesivir experimental medicine was administered to him for three days. (CTK Photo/Michal Krumphanzl)

E

Martin Balik, David Feltl

Doctor Martin Balik, left, and director of the General Teaching Hospital in Prague David Feltl, right, speak during a press conference on coronavirus treatment, on March 27, 2020, in Prague, Czech Republic. The condition of a Czech COVID-19 patient has markedly improved after the U.S. remdesivir experimental medicine was administered to him for three days. (CTK Photo/Michal Krumphanzl)

E

Martin Balik, David Feltl

Doctor Martin Balik, left, and director of the General Teaching Hospital in Prague David Feltl, right, speak during a press conference on coronavirus treatment, on March 24, 2020, in Prague, Czech Republic. The hospital received the remdesivir novel antiviral drug and it started administering it to a patient seriously ill with COVID-19. (CTK Photo/Ondrej Deml)

E

Martin Balik

Doctor Martin Balik of the General Teaching Hospital in Prague speaks during a press conference on coronavirus treatment, on March 24, 2020, in Prague, Czech Republic. The hospital received the remdesivir novel antiviral drug and it started administering it to a patient seriously ill with COVID-19. (CTK Photo/Ondrej Deml)